Abstract:Glucose transporters GLUT1 belong to the major facilitator superfamily and are essential to human glucose uptake. The overexpression of GLUT1 in tumor cells designates it as a pivotal target for glycoconjugate anticancer drugs. However, the interaction mechanism of glycoconjugate drugs with GLUT1 remains largely unknown. Here, we employed all-atom molecular dynamics simulations, coupled to steered and umbrella sampling techniques, to examine the thermodynamics governing the transport of glucose and two glycoconjugate drugs (i.e., 6-D-glucose-conjugated methane sulfonate and 6-D-glucose chlorambucil) by GLUT1. We characterized the specific interactions between GLUT1 and substrates at different transport stages, including substrate recognition, transport, and releasing, and identified the key residues involved in these procedures. Importantly, our results described, for the first time, the free energy profiles of GLUT1-transporting glycoconjugate drugs, and demonstrated that H160 and W388 served as important gates to regulate their transport via GLUT1. These findings provide novel atomic-scale insights for understanding the transport mechanism of GLUT1, facilitating the discovery and rational design of GLUT1-targeted anticancer drugs.

What problem does this paper attempt to address?

The problem this paper attempts to address is: The interaction mechanism between glycoconjugate drugs and the glucose transporter protein GLUT1 is not well understood, which hinders the rational design of anti-cancer drugs targeting GLUT1. Specifically, the authors studied the transport process of glucose and two glycoconjugate drugs (6-D-glucose-mesylate and 6-D-glucose-chlorophenylcyclohexanol) through GLUT1 using all-atom molecular dynamics simulations combined with guided and umbrella sampling techniques to reveal their thermodynamic mechanisms. ### Main Issues: 1. **Interaction mechanism between glycoconjugate drugs and GLUT1**: Currently, there is little understanding of how glycoconjugate drugs interact with GLUT1 and the mechanism by which they are transported through GLUT1. 2. **Identification of key residues**: Identifying the GLUT1 residues that play a key role in the transport process, particularly those involved in substrate recognition, transport, and release. 3. **Transport free energy profile**: For the first time, describing the free energy profile of GLUT1 transporting glycoconjugate drugs, revealing the energy barriers during the transport process. 4. **Rational design of anti-cancer drugs**: Providing new insights into the transport mechanism of GLUT1 at the atomic scale, thereby promoting the discovery and rational design of anti-cancer drugs targeting GLUT1. ### Research Methods: - **All-atom molecular dynamics simulations**: Used to study the interactions between GLUT1 and substrates (glucose and glycoconjugate drugs). - **Guided and umbrella sampling techniques**: Used to explore the thermodynamic pathways during the transport process, particularly the energy changes at different transport stages. - **Structural analysis**: By analyzing the conformational changes of GLUT1 in different states, the role of key residues is determined. ### Main Findings: - **Transport mechanism**: Detailed description of the transport pathways of glucose and glycoconjugate drugs through GLUT1, including the stages of substrate recognition, transport, and release. - **Key residues**: Identified H160 and W388 as important "gating" residues that regulate the transport of glycoconjugate drugs. - **Energy barriers**: For the first time, described the free energy profile of GLUT1 transporting glycoconjugate drugs, revealing the main energy barriers during the transport process. - **Drug design**: These findings provide atomic-scale insights into the transport mechanism of GLUT1, aiding in the rational design of anti-cancer drugs targeting GLUT1. Through these studies, the authors hope to provide a theoretical basis and technical support for the development of more effective anti-cancer drugs targeting GLUT1.

Enhanced Sampling Molecular Dynamics Simulations Reveal Transport Mechanism of Glycoconjugate Drugs through GLUT1

Mechanistic Study of Human Glucose Transport Mediated by GLUT1

2-Deoxyglucose Conjugated Platinum (II) Complexes for Targeted Therapy: Design, Synthesis, and Antitumor Activity.

Identification of Novel Inhibitors of GLUT1 by Virtual Screening and Cell-Based Assays

GLUT1: a Promising Drug Target for Cancer Treatment

GLUT1-mediated Selective Tumor Targeting with Fluorine Containing Platinum(ii) Glycoconjugates.

Design, Synthesis of Novel Platinum(II) Glycoconjugates, and Evaluation of Their Antitumor Effects.

Structural Aspects of the Glucose and Monocarboxylate Transporters Involved in the Warburg Effect

Molecular Basis of Ligand Recognition and Transport by Glucose Transporters

5-Fluorocytosine–Sugar Conjugates for Glucose Transporter-Mediated Tumor Targeting: Synthesis, Cytotoxicity, and Cellular Uptake Mechanism

Tumor cell membrane-coated continuous electrochemical sensor for GLUT1 inhibitor screening

A Computational and Chemical Design Strategy for Manipulating Glycan‐Protein Recognition

The Progress and Development of GLUT1 Inhibitors Targeting Cancer Energy Metabolism

Sugar Modification Enhances Cytotoxic Activity of PAMAM-Doxorubicin Conjugate in Glucose-Deprived MCF-7 Cells – Possible Role of GLUT1 Transporter

Glucose transporters in cancer – from tumor cells to the tumor microenvironment

Structural Interpretation of the Alternating Access Mechanism of Glucose Transporters Gluts

Photochemically Controlled Release of the Glucose Transporter 1 Inhibitor for Glucose Deprivation Responses and Cancer Suppression Research

Envisioning Glucose Transporters (GLUTs and SGLTs) as Novel Intervention against Cancer: Drug Discovery Perspective and Targeting Approach

Identification of a Novel GLUT1 Inhibitor with in Vitro and in Vivo Anti-Tumor Activity.

Study on Saccharide–Glucose Receptor Interactions with the Use of Surface Plasmon Resonance

Molecular basis for inhibiting human glucose transporters by exofacial inhibitors